Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
Journal of Medical Economics
|
July 4, 2025
Cost-benefit analysis of a quadrivalent influenza vaccine in India
Agam Vora, Mangesh Tiwaskar, Hrishikesh D Pai, et al.
The Journal of the Association of Physicians of India
|
October 16, 2025
What Makes Cefpodoxime an Empiric Drug of Choice to Treat Lower Respiratory Tract Infections, including Acute Exacerbation of Chronic Obstructive Pulmonary Disease, in the Real-world Setting in India?
Deepak Talwar, Agam Vora, Chandrakant Tarke, et al.
The Journal of the Association of Physicians of India
|
July 3, 2020
API Guidelines on Immunizations during COVID 19 Pandemic
S Arulrhaj, Shashank R Joshi, Siddharth N Shah, et al.
The Journal of the Association of Physicians of India
|
August 21, 2025
Levodropropizine: Comprehensive Review of the Peripheral Antitussive
Sandeep Nayar, Agam Vora, Mangesh Tiwaskar, et al.
The Journal of the Association of Physicians of India
|
May 13, 2024
Defeating the Silent Enemy: Antimicrobial Resistance Looming as the Next Global Pandemic
Mangesh Tiwaskar, Agam Vora, Amit Saraf, et al.
The Journal of the Association of Physicians of India
|
June 17, 2024
Screening for Lung Cancer in India: Expert Opinion Statement
Agam Vora, T Balamugesh, Digambar Behera, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 1, 2020
Role of favipiravir in the treatment of COVID-19
Shashank Joshi, Jalil Parkar, Abdul Ansari, et al.
The Indian Journal of Tuberculosis
|
December 14, 2020
COVID-19 -Tuberculosis interactions: When dark forces collide
Zarir F Udwadia, Agam Vora, Awatansh R Tripathi, et al.
Pragmatic and Observational Research
|
June 3, 2022
Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India
Shashank Joshi, Agam Vora, K Venugopal, et al.
The Journal of the Association of Physicians of India
|
September 29, 2021
Expert Opinion on Usage of Pidotimod in Adult Patients with Chronic Obstructive Pulmonary Disease: An Indian Perspective
Ashok Mahashur, Agam Vora, Pradyut Waghray, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
Journal of Medical Economics
|
July 4, 2025
Cost-benefit analysis of a quadrivalent influenza vaccine in India
Agam Vora, Mangesh Tiwaskar, Hrishikesh D Pai, et al.
The Journal of the Association of Physicians of India
|
October 16, 2025
What Makes Cefpodoxime an Empiric Drug of Choice to Treat Lower Respiratory Tract Infections, including Acute Exacerbation of Chronic Obstructive Pulmonary Disease, in the Real-world Setting in India?
Deepak Talwar, Agam Vora, Chandrakant Tarke, et al.
The Journal of the Association of Physicians of India
|
July 3, 2020
API Guidelines on Immunizations during COVID 19 Pandemic
S Arulrhaj, Shashank R Joshi, Siddharth N Shah, et al.
The Journal of the Association of Physicians of India
|
August 21, 2025
Levodropropizine: Comprehensive Review of the Peripheral Antitussive
Sandeep Nayar, Agam Vora, Mangesh Tiwaskar, et al.
The Journal of the Association of Physicians of India
|
May 13, 2024
Defeating the Silent Enemy: Antimicrobial Resistance Looming as the Next Global Pandemic
Mangesh Tiwaskar, Agam Vora, Amit Saraf, et al.
The Journal of the Association of Physicians of India
|
June 17, 2024
Screening for Lung Cancer in India: Expert Opinion Statement
Agam Vora, T Balamugesh, Digambar Behera, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 1, 2020
Role of favipiravir in the treatment of COVID-19
Shashank Joshi, Jalil Parkar, Abdul Ansari, et al.
The Indian Journal of Tuberculosis
|
December 14, 2020
COVID-19 -Tuberculosis interactions: When dark forces collide
Zarir F Udwadia, Agam Vora, Awatansh R Tripathi, et al.
Pragmatic and Observational Research
|
June 3, 2022
Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India
Shashank Joshi, Agam Vora, K Venugopal, et al.
The Journal of the Association of Physicians of India
|
September 29, 2021
Expert Opinion on Usage of Pidotimod in Adult Patients with Chronic Obstructive Pulmonary Disease: An Indian Perspective
Ashok Mahashur, Agam Vora, Pradyut Waghray, et al.
Page
of 8